Predictive Oncology Inc (POAI)

NASDAQ
0.4100
-0.0161(-3.78%)
  • Volume:
    171,724
  • Day's Range:
    0.4010 - 0.4443
  • 52 wk Range:
    0.2486 - 1.4662

POAI Overview

Prev. Close
0.4261
Day's Range
0.401-0.4443
Revenue
1.45M
Open
0.4443
52 wk Range
0.2486-1.4662
EPS
-0.3
Volume
171,724
Market Cap
31.38M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
1,013,812
P/E Ratio
-
Beta
1.41
1-Year Change
-60.91%
Shares Outstanding
78,159,663
Next Earnings Date
Aug 17, 2022
What is your sentiment on Predictive Oncology?
or
Vote to see community's results!

Predictive Oncology Inc News

Predictive Oncology Inc Analysis

Predictive Oncology Inc Company Profile

Predictive Oncology Inc Company Profile

Predictive Oncology Inc. is a data and artificial intelligence (AI)-driven discovery services company. The Company provides predictive models of tumor drug response that are used to improve clinical outcomes for patients. It operates through four segments: Helomics, zPREDICTA, Soluble, and Skyline. The Helomics segment includes clinical testing and contract research services that include the application of AI. zPREDICTA specializes in organ-specific disease models that provide 3D reconstruction of human tissues, accurately representing each disease state and mimicking drug response, enabling accurate testing of anticancer agents. The Soluble segment provides services using a self-contained, automated system that conducts throughput, self-interaction chromatography screens using additives and excipients commonly included in protein formulations, resulting in soluble and physically stable formulations for biologics. The Skyline segment consists of the STREAMWAY System product sales.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesNeutralSellSellStrong SellStrong Sell
Technical IndicatorsNeutralStrong SellStrong SellBuyStrong Sell
SummaryNeutralStrong SellStrong SellNeutralStrong Sell
  • What a piece of ********
    1
    • The company is set to be a first mover in the artificial intelligence powered drug discovery market that will grow to $20 billion in the next three years.
      1
      • anyone doesn't have an opinion about POAI?
        0
        • Up 27.3% in AH. Great day over here :)
          0
          • This stock is a hidden gem 💎
            0
            • This comment didn’t age well…
              0
          • ??????
            0
            • 100 stock soon
              0
              • see you all at 3$
                0
                • Two Top Researchers find Breakthrough Discoveries using Predictive Oncology’s Wholly Owned Subsidiary, TumorGenesis’s Technology
                  0
                  • investing .com   why still no but the new news about poai company?
                    0